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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 














in the age of 
coronavirus 





 MERS-CoV and 
SARS-CoV-1 are 
known to cause 




 The pulmonary 
manifestations of 
C19 have been well 
described in the 
literature but 
emerging evidence 















C19  which may 
lead to improved 
clinical outcomes 




further studies are 
required  










The Lancet | 
Article 
 Analysis of 1128 
patients who had 
surgery between 1 





in half of patients 
with perioperative 
SARS-CoV-2 
infection and are 
associated with high 
mortality 
 Thresholds for 
surgery during the 
C19 pandemic 
should be raised 
compared to normal 
practice, especially 
in men aged 70 





to delay or avoid the 
need for surgery 
should be 
considered  







severity in patients 
with cancer in 







 Patients with cancer 
and COVID-19 were 
more likely to 
deteriorate into 
severe illness than 
those without 
cancer 
 Risk factors 
identified in this 











outcomes, and risk 
factors for mortality 
in patients with 
cancer and COVID-







 Patients with cancer 
and COVID-19 
admitted to hospital 
had a high case-





within 4 weeks 
before symptom 
onset and male sex, 
may help clinicians 
identify patients at 
high risk of dying 
Mortality | 
NCD 






30.05.2020 Early transmission 
of SARS-CoV-2 in 







 A molecular epidemiological study 
by a network of government and 
university laboratories of the first 
21 SARS-CoV-2 whole genomes 
sampled in the first port of entry, 
KwaZulu-Natal (KZN) during the 
first month of the epidemic 
 The early introduction of SARS-
CoV-2 in KZN included a localised 
hospital outbreak which may 
explain the initially high death 
rates in the province 
 The current high rate of 
transmission of C19 in the 
Western Cape and Eastern Cape 
highlights the need to strengthen 
local genomic surveillance in SA 
 
  


















 A survey run by WHO with 
responses from 155 
countries has shown that 
C19 significantly impacts 
health services for cancer, 
cardiovascular disease 
and diabetes 
 Countries must find 
innovative ways to 



















 Research suggests that 
behavioural health 
concerns should take a 
primary role in response 
to the pandemic 
 A four-step services 
system is proposed 
designed for 
implementation with a 
variety of different groups 
and reserves limited 
clinical services for the 














 Study to understand 
the public perception 
of socioeconomic 
crises and human 
stress in resource-
limited settings of 
Bangladesh during 
the C19 outbreak 






Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | Article type Author(s) 
01.06.2020 Covid-19 and health: five expert 
views 






May 2020 Towards universal health 
systems in the Covid-19 era: 
opportunities and threats 
ODI | Briefing paper Emma Samman 
29.05.2020 All eyes are on local 
humanitarian responders during 
Covid-19 – now they need 
support 
ODI | Comment John Bryant 
01.06.2020 COVID-19 significantly impacts 
health services for 
noncommunicable diseases 
WHO | News release  
29.05.2020 The South African Response to 
the Pandemic 
NEJM | Correspondence Salim S. Abdool 
Karim 
29.05.2020 The right to health must guide 
responses to COVID-19 
The Lancet | Comment Dainius Puras 
Judith Bueno de 
Mesquita 
Luisa Cabal  
Allan Maleche 
Benjamin  Mason 
Meier 
6 
29.05.2020 Lockdown poses new 
challenges for cancer care in 
India 
The Lancet Oncology | 
News 
Dinesh C. Sharma 
29.05.2020 Poor clinical outcomes for 
patients with cancer during the 
COVID-19 pandemic 
The Lancet Oncology | 
Comment 
Liang V Tang 
Yu Hu 
27.05.2020 Tracking the genomic footprints 
of SARS-CoV-2 transmission 
Cell | Spotlight Tommy Tsan-Yuk 
Lam 

























































































































      
Global 
5050 









  US   Clinicaltrials.g
ov 




       UKCDR       
Information 
is Beautiful 
              
LSHTM               
HealthMap 
(cases) 




              
  
8 
C19 Resource Hubs 






















LSTM Stop TB 
Partnership 








  IDA 





ICL MRC Centre for Global 
































Johns Hopkins University RBM 
Partnership 










Center for Global 
Development 





UN Women Africa 
Evidence 
Network 











Norwegian Institute of 
Public Health 
    






Oxford Centre for 
Evidence-based Medicine 
    





 HEART     
UNESCO   NEJM  UKRI     
UN WFP   Oxford 
Universit
y Press 
 Evidence Aid     
GOARN   PLoS  NIH     
EPI-WIN   SAGE 
journals 
IFPRI Resources and 
Analyses of C19 Impact 
    
World Bank   Science  Prevent Epidemics      
Our World in 
Data 
  Springer 
Nature 





  SSRN 
(Preprint
s)  
      














      
WorldPop           
Flowminder           





    
  
Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
15.06.2020 Poverty monitoring in 
the context of Covid-
19 




Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 





on COVID-19 and 






WHO Academy and 
WHO Info mobile 
applications 





















5 hours Johns Hopkins 






5 sessions 1h 30 International Initiative 











online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 





























the Novel Coronavirus 
Online 
learning 




































of Edinburgh & Royal 
College of Physicians 













Millington, K.A. and Reddin, S. (2020). COVID-19 Health Evidence Summary No.51. K4D 
Evidence Summary. Brighton, UK: Institute of Development Studies. 
Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
13 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
